InMed Pharmaceuticals Inc. Business Finance Contracts & Agreements
38 Contracts & Agreements
- Assignment Agreements (3 contracts)
- Purchase Agreements (9)
- Registration Rights Agreements (6)
- Share Agreements (2)
- Stock Agreements (2)
- Underwriting Agreements (3)
- Warrant Agreements (13)
- Standby Equity Purchase Agreement, dated December 13, 2024, between InMed Pharmaceuticals Inc. and YA II PN, Ltd (Filed With SEC on December 18, 2024)
- Registration Rights Agreement (Filed With SEC on October 30, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on October 30, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 30, 2023)
- Registration Rights Agreement (Filed With SEC on November 22, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on November 22, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on November 22, 2022)
- Form of Registration Rights Agreement (Filed With SEC on September 14, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on September 14, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on September 14, 2022)
- Registration Rights Agreement (Filed With SEC on June 6, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on June 6, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on June 6, 2022)
- Warrant Amendment Agreement (Filed With SEC on June 6, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on June 6, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on June 6, 2022)
- Form of Amendment of Purchase Agreement and Common Stock Purchase Warrant, dated March 21, 2022 (Filed With SEC on March 22, 2022)
- Form of Specific Common Share Certificate (Filed With SEC on July 13, 2021)
- Form of Registration Rights Agreement (Filed With SEC on June 30, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on June 30, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on June 30, 2021)
- Form of Series A Warrant (Filed With SEC on June 30, 2021)
- Form of Registration Rights Agreement (Filed With SEC on February 5, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on February 5, 2021)
- Form of Common Share Purchase Warrant (Filed With SEC on February 5, 2021)
- Form of Public Warrant (Filed With SEC on November 12, 2020)
- Underwriting Agreement, dated November 12, 2020, by and between InMed Pharmaceuticals Inc. and Roth Capital Partners, LLC, as representative of the underwriters named therein (Filed With SEC on November 12, 2020)
- Form of Public Warrant (Filed With SEC on October 8, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on October 8, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 15, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 6, 2020)
- Amendment No. 1 to Technology Assignment Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)
- Technology Assignment Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)
- Assignment of Intellectual Property, dated as of October 28, 2015, between Dr. Sazzad Hossain and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)
- Section 85 Purchase and Sale Agreement, dated as of October 28, 2015, between Dr. Sazzad Hossain and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)
- Share Purchase Agreement, dated May 10, 2014, among Meridex Software Corporation, Biogen Sciences Inc. and the Shareholders of Biogen Sciences Inc (Filed With SEC on June 19, 2020)
- Form of Stock Option Agreement pursuant to the InMed Pharmaceuticals Inc. 2017 Stock Option Plan (Filed With SEC on June 19, 2020)
- InMed Pharmaceuticals Inc. 2017 Stock Option Plan (Filed With SEC on June 19, 2020)
